Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Congenital Hip Dysplasia
and you are
between 1 and 2
years old
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

The aim of this study is to prove the improvement of pubo-femoral distance by early abduction splintage in one-month-old infants with developmental dysplasia of the hip (with a clinical stable hip but an abnormal hip ultrasonography).

Provided treatments

  • Device: Abduction splintage
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02885831. The sponsor of the trial is University Hospital, Brest and it is looking for 90 volunteers for the current phase.
Official trial title:
Early Abduction Splintage on Stable Hips in Infants With Developmental Dysplasia of the Hip : Improvement or Overtreatment ?